Evidence map›Paper›PMID 41981147›Full record

ArticleScientific reports2026

Intelligent diagnosis of ovarian cancer in PET/CT imaging based on KiteNet-MobileNetv3 fusion and CarveMix augmentation.

Junwei Li, Kai Hu, Xueru Fan, Sisheng Wang, Tao He, Caiyun Xu, Qiwen Cai, Jinyan Chen, Yating Ling, Jianmin Yang and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Junwei Li *Pharmaceutical Informatics Institute, School of Pharmacy and Women's Hospital, School of Medicine, Zhejiang University, #866 Yuhangtang Road, Hangzhou, 310058, China.
Kai Hu *School of Mathematical Sciences, Zhejiang University, #866 Yuhangtang Road, Hangzhou, 310027, China.
Xueru Fan *Pharmaceutical Informatics Institute, School of Pharmacy and Women's Hospital, School of Medicine, Zhejiang University, #866 Yuhangtang Road, Hangzhou, 310058, China.
Sisheng WangSchool of Mathematical Sciences, Zhejiang University, #866 Yuhangtang Road, Hangzhou, 310027, China.
Tao HePharmaceutical Informatics Institute, School of Pharmacy and Women's Hospital, School of Medicine, Zhejiang University, #866 Yuhangtang Road, Hangzhou, 310058, China.
Caiyun XuNuclear Medicine Department, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310006, China.
Qiwen CaiSchool of Mathematical Sciences, Zhejiang University, #866 Yuhangtang Road, Hangzhou, 310027, China.
Jinyan ChenNuclear Medicine Department, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310006, China.
Yating LingSchool of Mathematical Sciences, Zhejiang University, #866 Yuhangtang Road, Hangzhou, 310027, China.
Jianmin YangSport Hospital of Zhejiang College of Sports, Hangzhou, 311231, China.
Xiaohui FanPharmaceutical Informatics Institute, School of Pharmacy and Women's Hospital, School of Medicine, Zhejiang University, #866 Yuhangtang Road, Hangzhou, 310058, China.
Dexing KongSchool of Mathematical Sciences, Zhejiang University, #866 Yuhangtang Road, Hangzhou, 310027, China. dkong@zju.edu.cn.
Lixia ZhangNuclear Medicine Department, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310006, China. 353826107@qq.com.
Lu LiPharmaceutical Informatics Institute, School of Pharmacy and Women's Hospital, School of Medicine, Zhejiang University, #866 Yuhangtang Road, Hangzhou, 310058, China. luciali@zju.edu.cn.

Funding

National Key Research and Development Program of China 2023YFC3504600National Natural Science Foundation of Zhejiang Province LY20H180004The High-level Talents Special Support Program of Zhejiang Province 2024-KYY-GXJS-0026The Zhejiang Province Traditional Chinese Medicine Science and Technology Project GZY-ZJKJ-24076Transverse Research Project of Zhejiang University 2023-KYY-A070350007
6 · The paper itself

Abstract

Ovarian cancer refers to a malignant tumor that grows in the ovary, which has the highest mortality rate of gynecological cancers. Positron emission tomography and computer tomography (PET/CT) imaging is widely used for the localization and characterization of ovarian tumors, but its analysis is susceptible to the subjectivity of clinicians. A deep learning-based PET/CT image diagnosis approach was investigated to achieve the segmentation and classification of ovarian tumors. We proposed several traditional convolutional neural networks (CNNs) for automatic ovarian tumors segmentation and classification. For segmentation, we design a hybrid network that integrates U-Net-MobileNetv3 with KiteNet to jointly capture global structure and lesion edge details, further enhanced by lesion-aware CarveMix augmentation and Dice-CE loss. For classification, we adopt ConvNeXt as the backbone and improve its robustness via Mixup data augmentation. Our method achieves a Dice coefficient of 0.826 and an accuracy of 0.912, outperforming all baseline models including U-Net, Deeplabv3, DenseNet, and Swin-Transformer. 1228 PET/CT images were employed to train and evaluate the CNN approach. Our segmentation model obtained a Dice of 0.826 compared to 0.773 obtained by U-Net-MobileNetv3, 0.444 by KiteNet, 0.634 by FCN, 0.744 by Deeplabv3, 0.667 by U-Net, and 0.747 by U-Net-VGG. Our classification model achieved the ACC of 0.912 compared to 0.907 achieved by ConvNeXt, 0.898 by DenseNet, 0.895 by EfficientNet and 0.848 by Swin-Transformer. In this study, we developed a novel deep learning framework for the simultaneous segmentation and classification of ovarian tumors in PET/CT imaging. Our key findings are: (1) A hybrid segmentation architecture that integrates U-Net-MobileNetv3 with KiteNet, enhanced by lesion-aware CarveMix augmentation and Dice-CE loss, achieved a Dice coefficient of 0.826, significantly outperforming standard models such as U-Net (0.667) and Deeplabv3 (0.744); (2) A classification pipeline based on ConvNeXt with Mixup data augmentation attained an accuracy of 0.912, surpassing DenseNet (0.898) and Swin-Transformer (0.848). These results demonstrate that our method can effectively support clinicians in both precise tumor delineation and reliable benign/malignant differentiation, offering a promising tool for intelligent ovarian cancer diagnosis.

Indexed as

Ovarian NeoplasmsPositron Emission Tomography Computed TomographyConvolutional Neural NetworksDeep LearningFemaleHumansImage Processing, Computer-AssistedConvolutional neural networkDeep learningIntelligent diagnosisOvarian cancerPET/CT

Identifiers

PMID41981147
PMCPMC13237279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.